We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GeneCloud - Semantic High Performance Cloud Computing Software for the Life Sciences
News

GeneCloud - Semantic High Performance Cloud Computing Software for the Life Sciences

GeneCloud - Semantic High Performance Cloud Computing Software for the Life Sciences
News

GeneCloud - Semantic High Performance Cloud Computing Software for the Life Sciences

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "GeneCloud - Semantic High Performance Cloud Computing Software for the Life Sciences"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The German Federal Ministry of Economics and Technology (BMWi) announced the 12 winners of the Trusted Cloud research program at the 2011 CeBIT in Hannover. Trusted Cloud fosters the development of secure cloud computing services. A total of 116 proposals were submitted to the 100 Mio Euro program.

GeneCloud, a proposal developed by Transinsight, TU Dresden, Antibodies Online, RESprotect, and Qualitype was selected as one of the 12 winners. The goal of GeneCloud is the development of cloud computing services for the life sciences.

The main problem for small and medium sized enterprises in the pharmaceutical industry is the access to high performance computing to analyze high-throughput experiments. In drug development, prediction of biomarkers, drug-target interactions and side effects are computationally intensive problems that will benefit from cloud computing.

"In order to better understand and treat diseases such as cancer, data analysis and computing plays an increasing role. Small companies should be enabled to use today’s computing power available in the cloud. However, the key problem is data security. Up to now there is a great barrier to release relevant data into the cloud. This problem is addressed in GeneCloud: we develop secure high-performance cloud computing services for the Life Science", says Dr. Michael R. Alvers, CEO of Transinsight.

Prof. Dr. Michael Schroeder of TU Dresden states: "The understanding of protein- and gene-networks is of high relevance to develop medicine faster, cheaper and with less side effects. In GeneCloud we will adopt our state-of-the-art award-winning algorithms to the needs of small players. By a combination of cryptography and stenography we will secure critical data, that no one else but the owner can get insights provided by the cloud computers".

On top of winning the Trusted Cloud competition, Transinsight was awarded with the German Innovation Prize IT for its outstanding developments in Enterprise Semantic Intelligence at CeBIT 2011. The prize was given to 43 companies and research groups out of over 2000 submissions.

Advertisement